International Journal of Antibiotics

International Journal of Antibiotics [2584-2986(e)] is a peer-reviewed open-access journal launched in 2024 that publishes original research articles, reviews, and perspectives in the field of antibiotics and antimicrobial agents. The journal aims to provide a platform for researchers, clinicians, and scientists to publish their findings and insights on the latest developments in the field of antibiotics.

The journal welcomes original research articles, reviews, and perspectives on any aspect of antibiotics and antimicrobial agents, including but not limited to, basic research, clinical trials, epidemiological studies, and policy and practice. The journal also encourages submissions from a broad range of disciplines, including microbiology, pharmacology, immunology, infectious diseases, and public health.

The journal aims to disseminate new knowledge and insights that can contribute to improving the use and effectiveness of antibiotics, as well as to reduce the development and spread of antibiotic resistance.

• • Antibiotic Discovery and Development: Target identification, high-throughput screening, structure-based drug design, lead optimization, chemical synthesis, natural product discovery, preclinical development.
  • Antibiotic Resistance and Mechanisms of Action: Antibiotic targets, multidrug resistance, resistance genes, efflux pumps, antibiotic-modifying enzymes, beta-lactamases, quinolone and aminoglycoside resistance, resistance evolution, horizontal gene transfer, fitness cost.
  • Antibiotic Pharmacology and Pharmacokinetics: Absorption, distribution, metabolism, and excretion, clearance, bioavailability, half-life, tissue penetration, plasma protein binding, drug interactions, therapeutic drug monitoring, pharmacodynamics, minimum inhibitory concentration, time-kill assays, post-antibiotic effect.
  • Antimicrobial Stewardship and Prescribing Practices: Stewardship programs, prescribing guidelines, antibiotic selection, empiric therapy, de-escalation, duration of therapy, antimicrobial formularies, clinical decision support systems, antibiotic allergy, antibiotic-related adverse events, prescriber education, antibiotic policy.
  • Clinical Trials and Outcomes of Antibiotic Therapy: Randomized controlled trials, observational and non-randomized studies, treatment efficacy and failure, clinical and microbiological outcomes, safety and tolerability, dosage regimens, route of administration, combination therapy.
  • Epidemiology and Surveillance of Antibiotic-Resistant Infections: Healthcare-associated and community-acquired infections, resistance patterns, outbreak investigation, molecular epidemiology, genotyping and phenotyping, antimicrobial susceptibility testing, surveillance systems, antimicrobial use monitoring, infection prevention and control.
  • New Technologies and Approaches for Antibiotic Research and Development: Genome mining, metagenomics, synthetic biology, CRISPR-based tools, proteomics, transcriptomics, systems biology, nanotechnology-based drug delivery, antibiotic adjuvants.
  • Veterinary and Agricultural Use of Antibiotics: Antibiotic use and resistance in livestock, poultry, swine, and aquaculture, feed additives and growth promoters, prophylactic and therapeutic use in animals, antibiotic residues, food safety, zoonotic infections, veterinary stewardship, One Health approaches.
  • Alternative Antimicrobial Therapies and Approaches: Antimicrobial and host defense peptides, bacteriophage therapy, probiotics, prebiotics, and postbiotics, plant extracts and essential oils, vaccines, immunotherapy, photodynamic therapy, ultrasound therapy, hyperthermia, cold plasma, electrolyzed water, antimicrobial nanoparticles.

  The journal publishes original research articles, reviews, and perspectives spanning basic science, clinical trials, epidemiology, and policy and practice. General infectious disease, microbiology, or pharmacology studies with no link to antimicrobial agents, their use, or resistance are out of scope. The journal serves microbiologists, pharmacologists, immunologists, infectious disease clinicians, clinical pharmacists, veterinarians, epidemiologists, and public health policymakers.